Christian Beltinger

Prof. Christian Beltinger


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
CDCarmen Dorneburg
Carmen Dorneburg
MFMatthias Fischer
Matthias Fischer
TBThomas F.E. Barth
Thomas F.E. Barth
WMWolfgang Mueller-Klieser
Wolfgang Mueller-Klieser
BHBarbara Hero
Barbara Hero
CBChristian Beltinger
Christian Beltinger
Purpose: To investigate whether lactate dehydrogenase A (LDHA), an important component of the LDH tetramer crucial for aerobic glycolysis, is associated with patient outcome and constitutes a therapeutic target in neuroblastoma (NB). Experimental Design: Expression of LDHA mRNA and protein was determined in 709 and 110 NB patient samples, respectively, and correlated to survival and risk factors. LDHA and LDHB were depleted in human NB cell lines by CRISPR/Cas9 and shRNA, respectively, and aerobic glycolysis, clonogenicity and tumorigenicity were determined. Expression of LDHA in relation to MYCN was measured in NB cell lines and in the TH-MYCN NB mouse model. Results: Expression of LDHA, both on the mRNA and the protein level, was significantly and independently associated with decreased patient survival. Predominant cytoplasmic localization of LDHA protein was associated with poor outcome. Amplification and expression of MYCN did not correlate with expression of LDHA in NB cell lines or TH-MYCN mice, respectively. Knockout of LDHA inhibited clonogenicity, tumorigenicity and tumor growth without abolishing LDH activity or significantly decreasing aerobic glycolysis. Concomitant depletion of LDHA and the isoform LDHB ablated clonogenicity while not abrogating LDH activity or decreasing aerobic glycolysis. The isoform LDHC was not expressed. Conclusions: High expression of LDHA is independently associated with poor outcome of NB and NB cells can be inhibited by depletion of LDHA or LDHB. This inhibition appears to be unrelated to LDH activity and aerobic glycolysis. Thus, investigations of inhibitory mechanisms beyond attenuation of aerobic glycolysis are warranted, both in NB and normal cells.

1 February 2016 in Cancer Letters
Verified
Journal Article
Closed access
MDMeike Dahlhaus
Meike Dahlhaus
ABAndre Burkovski
Andre Burkovski
FHFalk Hertwig
Falk Hertwig
CMChristoph Mussel
Christoph Mussel
RVRuth Volland
Ruth Volland
CBChristian Beltinger
Christian Beltinger

10 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSShobhit Saxena
Shobhit Saxena
JWJoachim Wahl
Joachim Wahl
MHMarkus S. Huber-Lang
Markus S. Huber-Lang
DSDominic Stadel
Dominic Stadel
PBPeter Braubach
Peter Braubach
CBChristian Beltinger
Christian Beltinger
Sympathoadrenergic progenitor cells (SAPs) of the peripheral nervous system (PNS) are important for normal development of the sympathetic PNS and for the genesis of neuroblastoma, the most common and often lethal extracranial solid tumor in childhood. However, it remains difficult to isolate sufficient numbers of SAPs for investigations. We therefore set out to improve generation of SAPs by using two complementary approaches, differentiation from murine embryonic stem cells (ESCs) and isolation from postnatal murine adrenal glands. We provide evidence that selecting for GD2 expression enriches for ESC-derived SAP-like cells and that proliferating SAP-like cells can be isolated from postnatal adrenal glands of mice. These advances may facilitate investigations about the development and malignant transformation of the sympathetic PNS.

17 November 2021 in Oncogene
Verified
Journal Article
Open access
PDF file
ALAstrid K. Laut
Astrid K. Laut
CDCarmen Dorneburg
Carmen Dorneburg
AFAxel Fürstberger
Axel Fürstberger
TBThomas FE Barth
Thomas FE Barth
HKHans Kestler
Hans Kestler
CBChristian Beltinger
Christian Beltinger
CHD5, a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm that low expression of CHD5 is associated with stage 4 NB. Forced expression of CHD5 in NB cell lines with 1p loss inhibited key aspects of the metastatic cascade in vitro: anchorage-independent growth, migration, and invasion. In vivo, formation of bone marrow and liver metastases developing from intravenously injected NB cells was delayed and decreased by forced CHD5 expression. Genome-wide mRNA sequencing revealed reduction of genes and gene sets associated with metastasis when CHD5 was overexpressed. Known metastasis-suppressing genes preferentially upregulated in CHD5-overexpressing NB cells included PLCL1. In patient NB, low expression of PLCL1was associated with metastatic disease and poor survival. Knockdown of PLCL1 and of p53 in IMR5 NB cells overexpressing CHD5 reversed CHD5-induced inhibition of invasion and migration in vitro. In summary, CHD5 is a metastasis suppressor in NB.

27 March 2008 in Gene Therapy
Verified
Journal Article
Closed access
KDK-M Debatin
K-M Debatin
JWJ Wei
J Wei
CBChristian Beltinger
Christian Beltinger

30 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CDCarmen Dorneburg
Carmen Dorneburg
AGAnnika V. Goß
Annika V. Goß
MFMatthias Fischer
Matthias Fischer
FRFrederik Roels
Frederik Roels
TBThomas F.E. Barth
Thomas F.E. Barth
CBChristian Beltinger
Christian Beltinger
γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets